KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling

Molecular and Cellular Endocrinology

Volumn 371, Issue 1-2, 2013, Pages 221-227

  Boulkroun, Sheerazed ^a,b   Golib Dzib, José Felipe ^c   Samson Couterie, Benoit ^a,b   Rosa, Fabio Luiz Fernandes ^a,b   Rickard, Amanda Jane ^a,b   Meatchi, Tchao ^a,b,d   Amar, Laurence ^a,b,d   Benecke, Arndt ^c   Zennaro, Maria Christina ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CNRS   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Adrenal cortex; Aldosterone producing adenoma; KCNJ5 mutations; Primary aldosteronism; Zona glomerulosa

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; MESSENGER RNA; PROTEIN KCNJ5; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ARTICLE; CELL COMPOSITION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE STRUCTURE; HISTOPATHOLOGY; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KCNJ5 GENE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOMATIC MUTATION; TUMOR VASCULARIZATION; ZONA GLOMERULOSA;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ALDOSTERONE; ALDOSTERONE SYNTHASE; CELL PROLIFERATION; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HUMANS; MALE; MUTATION; RNA, MESSENGER; ZONA GLOMERULOSA;

EID: 84876088023     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.01.018     Document Type: Article

References (23)

1. Akerstrom T., Crona J., Delgado Verdugo A., Starker L.F., Cupisti K., Willenberg H.S., Knoefel W.T., Saeger W., Feller A., Ip J., Soon P., Anlauf M., Alesina P.F., Schmid K.W., Decaussin M., Levillain P., Wangberg B., Peix J.L., Robinson B., Zedenius J., Backdahl M., Caramuta S., Iwen K.A., Botling J., Stalberg P., Kraimps J.L., Dralle H., Hellman P., Sidhu S., Westin G., Lehnert H., Walz M.K., Akerstrom G., Carling T., Choi M., Lifton R.P., Bjorklund P. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS ONE 2012, 7:e41926.
2. Azizan E.A., Lam B.Y., Newhouse S.J., Zhou J., Kuc R.E., Clarke J., Happerfield L., Marker A., Hoffman G.J., Brown M.J. Microarray, qPCR, and KCNJ5 Sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. J. Clin. Endocrinol. Metab. 2012, 97:E819-829.
3. Azizan E.A., Murthy M., Stowasser M., Gordon R., Kowalski B., Xu S., Brown M.J., O'Shaughnessy K.M. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension 2012, 59:587-591.
4. Bandulik S., Penton D., Barhanin J., Warth R. TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation. Horm. Metab. Res. 2010, 42:450-457.
5. Boulkroun S., Beuschlein F., Rossi G.P., Golib-Dzib J.F., Fischer E., Amar L., Mulatero P., Samson-Couterie B., Hahner S., Quinkler M., Fallo F., Letizia C., Allolio B., Ceolotto G., Cicala M.V., Lang K., Lefebvre H., Lenzini L., Maniero C., Monticone S., Perrocheau M., Pilon C., Plouin P.F., Rayes N., Seccia T.M., Veglio F., Williams T.A., Zinnamosca L., Mantero F., Benecke A., Jeunemaitre X., Reincke M., Zennaro M.C. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 2012, 59:592-598.
6. Boulkroun S., Samson-Couterie B., Dzib J.F., Lefebvre H., Louiset E., Amar L., Plouin P.F., Lalli E., Jeunemaitre X., Benecke A., Meatchi T., Zennaro M.C. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension 2010, 56:885-892.
7. Boulkroun S., Samson-Couterie B., Golib-Dzib J.F., Amar L., Plouin P.F., Sibony M., Lefebvre H., Louiset E., Jeunemaitre X., Meatchi T., Benecke A., Lalli E., Zennaro M.C. Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers. Endocrinology 2011, 152:4753-4763.
8. Calhoun D.A., Nishizaka M.K., Zaman M.A., Thakkar R.B., Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002, 40:892-896.
9. + channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 2011, 331:768-772.
10. Geller D.S., Zhang J., Wisgerhof M.V., Shackleton C., Kashgarian M., Lifton R.P. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 2008, 93:3117-3123.
11. Guagliardo N.A., Yao J., Hu C., Schertz E.M., Tyson D.A., Carey R.M., Bayliss D.A., Barrett P.Q. TASK-3 channel deletion in mice recapitulates low-renin essential hypertension. Hypertension 2012, 59:999-1005.
12. Hannemann A., Bidlingmaier M., Friedrich N., Manolopoulou J., Spyroglou A., Volzke H., Beuschlein F., Seissler J., Rettig R., Felix S.B., Biffar R., Doring A., Meisinger C., Peters A., Wichmann H.E., Nauck M., Wallaschofski H., Reincke M. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur. J. Endocrinol. 2012, 167:7-15.
13. Lenzini L., Seccia T.M., Aldighieri E., Belloni A.S., Bernante P., Giuliani L., Nussdorfer G.G., Pessina A.C., Rossi G.P. Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension 2007, 50:1106-1113.
14. Letavernier E., Peyrard S., Amar L., Zinzindohoue F., Fiquet B., Plouin P.F. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J. Hypertens. 2008, 26:1816-1823.
15. Monticone S., Hattangady N.G., Nishimoto K., Mantero F., Rubin B., Cicala M.V., Pezzani R., Auchus R.J., Ghayee H.K., Shibata H., Kurihara I., Williams T.A., Giri J.G., Bollag R.J., Edwards M.A., Isales C.M., Rainey W.E. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J. Clin. Endocrinol. Metab. 2012, 97:E1567-1572.
16. Mulatero P., Tauber P., Zennaro M.C., Monticone S., Lang K., Beuschlein F., Fischer E., Tizzani D., Pallauf A., Viola A., Amar L., Williams T.A., Strom T.M., Graf E., Bandulik S., Penton D., Plouin P.F., Warth R., Allolio B., Jeunemaitre X., Veglio F., Reincke M. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension 2012, 59:235-240.
17. Nishimoto K., Nakagawa K., Li D., Kosaka T., Oya M., Mikami S., Shibata H., Itoh H., Mitani F., Yamazaki T., Ogishima T., Suematsu M., Mukai K. Adrenocortical zonation in humans under normal and pathological conditions. J. Clin. Endocrinol. Metab. 2010, 95:2296-2305.
18. Oki K., Plonczynski M.W., Luis Lam M., Gomez-Sanchez E.P., Gomez-Sanchez C.E. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology 2012, 153:1774-1782.
19. Penton D., Bandulik S., Schweda F., Haubs S., Tauber P., Reichold M., Cong L.D., El Wakil A., Budde T., Lesage F., Lalli E., Zennaro M.C., Warth R., Barhanin J. Task3 potassium channel gene invalidation causes low renin and salt-sensitive arterial hypertension. Endocrinology 2012, 153:4740-4748.
20. Sasano H. Localization of steroidogenic enzymes in adrenal cortex and its disorders. Endocr. J. 1994, 41:471-482.
21. Scholl U.I., Nelson-Williams C., Yue P., Grekin R., Wyatt R.J., Dillon M.J., Couch R., Hammer L.K., Harley F.L., Farhi A., Wang W.H., Lifton R.P. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc. Natl. Acad. Sci. USA 2012, 109:2533-2538.
22. Taguchi R., Yamada M., Nakajima Y., Satoh T., Hashimoto K., Shibusawa N., Ozawa A., Okada S., Rokutanda N., Takata D., Koibuchi Y., Horiguchi J., Oyama T., Takeyoshi I., Mori M. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 2012, 97:1311-1319.
23. Williams T.A., Monticone S., Crudo V., Warth R., Veglio F., Mulatero P. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension 2012, 59:833-839.